FDA Approved: RETACRIT — Original Application (Vifor (International) Inc.)

View source ↗

Summary

The FDA approved Retacrit (epoetin alfa-epbx) under Original Application BLA125545, establishing it as a biosimilar to epoetin alfa. The approval covers treatme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Anemia
• Chronic Kidney Disease
• HIV Infection

Drugs mentioned

• RETACRIT (EPOETIN ALFA-EPBX)

Snippet

ORIG AP for RETACRIT (EPOETIN ALFA-EPBX)